What Happened?
Boca Raton, FL-based Connectyx Appointed Ronald Bordens as Executive Vice President of Technical Operations and Manufacturing
About the Company
Connectyx is a development-stage biomedical company focusing on novel treatments for rare diseases. In November, the Company announced it is changing its name to Curative Biotechnology, Inc. and has applied for the name change and a trading symbol (CURB) with the Financial Industry Regulatory Authority, Inc., which should take effect in the first quarter of 2021. Connectyx is focused on therapies with potentially accelerated development paths as a result of either the disease, the nature of the therapeutic itself, or the stage of clinical development. At the heart of the Company is a product development engine that rests on our unique S.O.A.R. filter (Science, Opportunity, Acceleration, Rare Disease.) At Connectyx, we envision a world where all patients have a therapeutic option.
About the Person
Ronald Bordens is Executive Vice President of Technical Operations and Manufacturing at Connectyx. Previously, Ronald held various senior IT leadership roles in the industry.
Info Source
News
Short Profile